267
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Baseline Serum BCAAs are Related to the Improvement in Insulin Resistance in Obese People After a Weight Loss Intervention

, ORCID Icon, , &
Pages 179-186 | Received 30 Aug 2022, Accepted 06 Jan 2023, Published online: 19 Jan 2023

References

  • Pan XF, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 2021;9(6):373–392. doi:10.1016/S2213-8587(21)00045-0
  • Newgard CB, An J, Bain JR, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9(4):311–326. doi:10.1016/j.cmet.2009.02.002
  • Lee J, Vijayakumar A, White PJ, et al. BCAA supplementation in mice with diet-induced obesity alters the metabolome without impairing glucose homeostasis. Endocrinology. 2021;162(7):bqab062. doi:10.1210/endocr/bqab062
  • Lu J, Gu Y, Liu H, et al. Daily branched-chain amino acid intake and risks of obesity and insulin resistance in children: a cross-sectional study. Obesity. 2020;28(7):1310–1316. doi:10.1002/oby.22834
  • Zheng Y, Ceglarek U, Huang T, et al. Weight-loss diets and 2-y changes in circulating amino acids in 2 randomized intervention trials. Am J Clin Nutr. 2016;103(2):505–511. doi:10.3945/ajcn.115.117689
  • Golzarand M, Toolabi K, Hedayati M, Azam K, Douraghi M, Djafarian K. Comparative study of resting metabolic rate and plasma amino acid profile in patients who underwent laparoscopic roux-en-y gastric bypass and laparoscopic sleeve gastrectomy: 6-month follow-up study. Obes Surg. 2019;29(10):3125–3132. doi:10.1007/s11695-019-03969-3
  • Senecal C, Widmer RJ, Larrabee BR, et al. A digital health weight loss program in 250,000 individuals. J Obes. 2020;2020:9497164. doi:10.1155/2020/9497164
  • Senecal C, Collazo-Clavell M, Larrabee BR, et al. A digital health weight-loss intervention in severe obesity. Digit Health. 2020;6:2055207620910279. doi:10.1177/2055207620910279
  • Wang X, Wang S, Zhang C, et al. Internet-based platform for a low-calorie dietary intervention involving prepackaged food for weight loss in overweight and obese individuals in China: protocol for a randomised controlled trial. BMJ Open. 2022;12(1):e048106. doi:10.1136/bmjopen-2020-048106
  • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419. doi:10.1007/BF00280883
  • Lean MEJ, Leslie WS, Barnes AC, et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol. 2019;7(5):344–355. doi:10.1016/S2213-8587(19)30068-3
  • Cheng D, Zhao X, Yang S, Cui H, Wang G. Metabolomic signature between metabolically healthy overweight/obese and metabolically unhealthy overweight/obese: a systematic review. Diabetes Metab Syndr Obes. 2021;14:991–1010. doi:10.2147/DMSO.S294894
  • Fontana L, Cummings NE, Arriola Apelo SI, et al. Decreased consumption of branched-chain amino acids improves metabolic health. Cell Rep. 2016;16(2):520–530. doi:10.1016/j.celrep.2016.05.092
  • Tan HC, Khoo CM, Tan MZ, et al. The effects of sleeve gastrectomy and gastric bypass on branched-chain amino acid metabolism 1 year after bariatric surgery. Obes Surg. 2016;26(8):1830–1835. doi:10.1007/s11695-015-2023-x
  • Lips MA, Van Klinken JB, van Harmelen V, et al. Roux-en-Y gastric bypass surgery, but not calorie restriction, reduces plasma branched-chain amino acids in obese women independent of weight loss or the presence of type 2 diabetes. Diabetes Care. 2014;37(12):3150–3156. doi:10.2337/dc14-0195
  • Zhou M, Shao J, Wu CY, et al. Targeting BCAA catabolism to treat obesity-associated insulin resistance. Diabetes. 2019;68(9):1730–1746. doi:10.2337/db18-0927
  • Yu D, Richardson NE, Green CL, et al. The adverse metabolic effects of branched-chain amino acids are mediated by isoleucine and valine. Cell Metab. 2021;33(5):905–922.e6. doi:10.1016/j.cmet.2021.03.025
  • Jang C, Oh SF, Wada S, et al. A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance. Nat Med. 2016;22(4):421–426. doi:10.1038/nm.4057
  • Bishop CA, Machate T, Henning T, et al. Detrimental effects of branched-chain amino acids in glucose tolerance can be attributed to valine induced glucotoxicity in skeletal muscle. Nutr Diabetes. 2022;12(1):20. doi:10.1038/s41387-022-00200-8
  • Lee S, Gulseth HL, Langleite TM, et al. Branched-chain amino acid metabolism, insulin sensitivity and liver fat response to exercise training in sedentary dysglycaemic and normoglycaemic men. Diabetologia. 2021;64(2):410–423. doi:10.1007/s00125-020-05296-0
  • Hu W, Yang P, Fu Z, et al. High L-Valine Concentrations associate with increased oxidative stress and newly-diagnosed type 2 diabetes mellitus: a cross-sectional study. Diabetes Metab Syndr Obes. 2022;15:499–509. doi:10.2147/DMSO.S336736
  • Li J, Cao YF, Sun XY, et al. Plasma tyrosine and its interaction with low high-density lipoprotein cholesterol and the risk of type 2 diabetes mellitus in Chinese. J Diabetes Investig. 2019;10(2):491–498. doi:10.1111/jdi.12898
  • Goffredo M, Santoro N, Tricò D, et al. A branched-chain amino acid-related metabolic signature characterizes obese adolescents with non-alcoholic fatty liver disease. Nutrients. 2017;9(7):642. doi:10.3390/nu9070642